Manchester mulls paying for medicines based on their efficacy https://t.co/il8Wk2dK9L via @FT
— The Propell Group (@ThePropellGroup) February 24, 2017
#healthtech
Manchester mulls paying for medicines based on their efficacy https://t.co/il8Wk2dK9L via @FT
— The Propell Group (@ThePropellGroup) February 24, 2017
#healthtech